Skip to main content
DA

DeepRad.AI

DeepRad.AI develops AI-driven medical imaging platforms, including DeepLung-CAC for lung cancer screening and DeepBrain-Cognito for cognitive assessment, utilizing advanced algorithms to analyze low-dose CT images and brain patterns. These technologies enhance early detection of conditions like lung cancer and dementia, improving diagnostic accuracy and patient outcomes in radiology.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

The increasing prevalence of lung cancer and cognitive decline necessitates early and accurate screening methods. Traditional diagnostic processes can be time-consuming and may not always detect subtle indicators of disease in their early stages. This can lead to delayed treatment and poorer patient outcomes.

Solution

DeepRad.AI develops AI-powered medical imaging platforms designed to enhance early detection of critical conditions. Their DeepLung-CAC platform analyzes low-dose CT images to screen for lung nodules, coronary artery calcifications, and bone density abnormalities in a single exam. DeepBrain-Cognito utilizes AI to identify patterns of regional brain cortical thinning, aiding in the early diagnosis of dementia. By automating workflow operations and serving as a medical assistant, DeepRad.AI's solutions aim to increase productivity for radiologists, accelerate screening workflows for hospitals, and empower patients with proactive healthcare choices through faster and more accurate screening.

Target Audience

DeepRad.AI's primary customers include radiologists, hospitals and health centers, insurance providers, and patients seeking proactive healthcare solutions.

Features

  • DeepLung-CAC: AI-powered analysis of low-dose CT images for lung cancer screening, coronary artery calcification detection, and bone density assessment.
  • DeepBrain-Cognito: AI-driven cognitive screening platform that portrays patterns of regional brain cortical thinning in 4D.
  • Automated workflow operations to increase radiologist productivity.
  • AI assistance to reduce errors in image analysis and reporting.
  • Opportunistic screening capabilities to increase revenue for hospitals and health centers.
  • AI-assisted decision-making system for persistent post-concussion syndrome, predicting symptom duration and offering personalized occupational therapy recommendations.
This profile is AI-generated and may contain inaccuracies.